Submit Article
Legal Analysis. Regulatory Intelligence. Jurisprudence.
Search articles, case studies, legal topics...
Singapore

Parastate Labs Inc v Wang Li and others [2023] SGHC 153

The court held that a Mareva injunction quantum should be set based on the applicant's ability to meet its undertaking as to damages, and that material non-disclosure (including failure to provide prescribed undertakings) is a relevant factor in determining whether to grant or li

300 wpm
0%
Chunk
Theme
Font

Case Details

  • Citation: [2023] SGHC 153
  • Court: General Division of the High Court of the Republic of Singapore
  • Decision Date: 26 May 2023
  • Coram: Andre Maniam J
  • Case Number: Originating Claim No 130 of 2022; Summons No 2564 of 2022
  • Hearing Date(s): 14 July 2022; 28 November 2022
  • Claimant: Parastate Labs Inc
  • Defendants: Wang Li (First Defendant); Yang Zhou (Second Defendant); Babel Asia Asset Management Private Limited (Third Defendant); Babel Holding Limited (Fourth Defendant)
  • Counsel for Claimant: Foo Maw Shen, Chu Hua Yi, and Mark Tan (FC Legal Asia LLC)
  • Counsel for First Defendant: Choo Zheng Xi and Carol Yuen (Remy Choo Chambers LLC)
  • Practice Areas: Civil Procedure; Mareva injunctions; Quantum of Mareva injunction; Cryptocurrency litigation

Summary

The decision in Parastate Labs Inc v Wang Li and others [2023] SGHC 153 serves as a critical reminder to practitioners that the "draconian" nature of Mareva relief requires more than just a "good arguable case" on the merits. It demands absolute transparency regarding the claimant’s financial capacity to honor its undertaking as to damages. In this instance, Parastate Labs Inc ("Parastate") sought a worldwide Mareva injunction against Mr. Wang Li, a co-founder of the "Babel Finance" cryptocurrency ecosystem, to secure a claim of US$5m arising from an investment in the Babel Quant Alpha USDT Fund. While the court was satisfied that the threshold for a good arguable case and a real risk of dissipation had been met, the application stumbled on the procedural and substantive requirements of the undertaking as to damages.

The central doctrinal contribution of this judgment lies in the court’s calibration of the injunction’s quantum as a response to unsatisfactory financial disclosure. Andre Maniam J held that where a claimant fails to provide clear, contemporary evidence of its assets—particularly when those assets are tied to the volatile cryptocurrency market—the court may exercise its discretion to limit the scope of the injunction. Parastate’s reliance on historical funding rounds totaling US$11.8m was deemed insufficient to prove current liquidity, especially given the lapse of time and the intervening "crypto winter" that had affected the very fund in which Parastate had invested.

Furthermore, the court addressed the impact of material non-disclosure and the failure to comply with the Supreme Court Practice Directions 2021. Parastate had omitted specific prescribed undertakings (Undertakings 9 and 10 of Form 25) which are designed to protect defendants against the enforcement of worldwide orders in foreign jurisdictions without the court's leave. This omission, coupled with the lack of transparency regarding the claimant's asset composition, led the court to halve the requested quantum. Instead of the US$5m sought, the court granted a Mareva injunction limited to US$2.5m.

This case underscores that the undertaking as to damages is not a mere formality but the "price" of the injunction. If the claimant cannot prove it can pay that price, the court will not grant the full measure of relief. The judgment provides a clear roadmap for how Singapore courts will treat cryptocurrency-related entities seeking emergency relief: historical "valuation" or "funding" figures will not substitute for a granular disclosure of current, realizable assets. For practitioners, the case is a stern warning that any deviation from the standard forms in the Practice Directions must be explicitly justified, or risk the dilution of the client's protective measures.

Timeline of Events

  1. 27 January 2021: Babel Holding Limited (the Fourth Defendant) is incorporated, with Mr. Wang Li (the First Defendant) holding a 30% shareholding and Mr. Yang Zhou (the Second Defendant) holding a 40% shareholding.
  2. 9 April 2021: Parastate Labs Inc enters into an investment agreement, investing US$5m into the Babel Quant Alpha USDT Fund (the "Fund").
  3. 14 July 2021: Relevant date in the factual matrix concerning the operational timeline of the Babel Finance ecosystem and its management by Babel Asia Asset Management Private Limited (the Third Defendant).
  4. Early 2022: The Babel Finance ecosystem, a cryptocurrency financial services provider, begins facing significant liquidity issues and financial distress.
  5. 14 July 2022: The first hearing date for Parastate’s application for a Mareva injunction (Summons No 2564 of 2022) in the High Court.
  6. 11 August 2022: Parastate files an affidavit in support of its application, asserting it had raised US$11.8m in funding over the preceding 1.5 years.
  7. 28 October 2022: Parastate files a further affidavit following the court's direction to provide more information regarding its ability to meet the undertaking as to damages.
  8. 28 November 2022: The substantive inter partes hearing of the Mareva injunction application takes place before Andre Maniam J.
  9. 26 May 2023: The High Court delivers its judgment, granting the Mareva injunction against Mr. Wang Li but reducing the quantum to US$2.5m.

What Were the Facts of This Case?

The dispute arose within the volatile context of the cryptocurrency markets. Parastate Labs Inc, the claimant, was an investor that had placed US$5m into the Babel Quant Alpha USDT Fund. This Fund was part of a larger ecosystem of cryptocurrency financial services operating under the brand "Babel Finance." The management of the Fund was handled by the Third Defendant, Babel Asia Asset Management Private Limited, which was a wholly-owned subsidiary of the Fourth Defendant, Babel Holding Limited. The First Defendant, Mr. Wang Li, and the Second Defendant, Mr. Yang Zhou, were co-founders of Babel Holding, holding 30% and 40% of the shares respectively at the time of incorporation.

The core of the grievance was the failure of the Babel Finance entities to return Parastate’s US$5m investment. As the Babel Finance ecosystem began to unravel, Parastate alleged that the individual defendants, particularly Mr. Wang, were responsible for the loss of the funds. Parastate initiated Originating Claim No 130 of 2022, seeking the recovery of its investment. To ensure that any future judgment would not be rendered nugatory, Parastate applied for a worldwide Mareva injunction against both Mr. Wang and Mr. Yang.

Initially, Parastate sought the injunction on an ex parte basis. However, the court declined to grant the relief without hearing the defendants and directed that the application proceed inter partes. By the time of the substantive hearing, Parastate narrowed its focus, seeking the injunction only against Mr. Wang. The quantum sought was US$5m, representing the principal amount of the investment.

The factual controversy centered on two main pillars: the merits of the claim and the financial standing of the claimant. Regarding the merits, Parastate alleged that Mr. Wang had mismanaged the Fund or otherwise breached duties that led to the disappearance of the US$5m. Mr. Wang contested these allegations, but the court found that there was a "good arguable case"—the requisite threshold for a Mareva injunction. The court also found a "real risk of dissipation" of assets by Mr. Wang, satisfying the second traditional requirement for such relief.

However, the case took a turn when the court examined Parastate’s ability to provide a meaningful undertaking as to damages. An undertaking as to damages is the claimant's promise to compensate the defendant for any losses caused by the injunction if it is later found that the injunction should not have been granted. To make this undertaking meaningful, the claimant must show it has sufficient assets to back the promise. Parastate’s evidence on this point was remarkably thin. It claimed to have raised US$11.8m in funding between early 2021 and mid-2022. However, it failed to provide a balance sheet, a statement of current assets, or any breakdown of how much of that US$11.8m remained. Crucially, it did not disclose whether its assets were held in fiat currency or cryptocurrency—the latter being subject to extreme price fluctuations.

The court noted that Parastate’s last funding round was more than a year prior to the hearing. Furthermore, Parastate had already used US$5m of its funds for the very investment that was now at the heart of the litigation. This left the court in a position of significant uncertainty regarding Parastate’s actual liquidity. The defendants argued that Parastate was essentially a "shell" or at least a financially opaque entity that could not be relied upon to satisfy a multi-million dollar damages claim if the injunction proved wrongful.

Adding to the factual complexity was Parastate’s procedural conduct. When filing its application, Parastate used a modified version of the standard Mareva injunction form. It deliberately omitted Undertakings 9 and 10 from Form 25 of the Supreme Court Practice Directions 2021. These undertakings are standard in worldwide Mareva orders; they require the claimant not to enforce the Singapore order in foreign jurisdictions without the Singapore court's permission. Parastate’s failure to include these, and its subsequent failure to provide a satisfactory explanation for the omission, became a focal point of the court's analysis of "clean hands" and material non-disclosure.

The application for the Mareva injunction raised several interconnected legal issues that required the court to balance the claimant’s need for security against the defendant’s right to be protected from the potential abuse of a "nuclear weapon" of civil litigation.

  • The Adequacy of the Undertaking as to Damages: Whether a claimant’s reliance on historical funding figures, without contemporary asset disclosure, is sufficient to support an undertaking as to damages for a multi-million dollar injunction.
  • The Impact of Material Non-Disclosure: Whether the deliberate omission of prescribed undertakings from the Supreme Court Practice Directions 2021, and the failure to disclose the composition of assets (fiat vs. crypto), constitutes material non-disclosure justifying the refusal or reduction of relief.
  • The "Just or Convenient" Requirement: Under section 4(10) of the Civil Law Act 1909, whether it was "just or convenient" to grant an injunction for the full US$5m when the claimant's financial transparency was lacking.
  • Calibration of Quantum: Whether the court has the discretion to grant a Mareva injunction for a lower amount than the "good arguable case" value as a means of mitigating the risk to the defendant where the claimant's undertaking is suspect.
  • Compliance with Practice Directions: The legal weight to be given to Form 25 of the Supreme Court Practice Directions 2021 and the necessity of providing the specific information required regarding the claimant's assets.

How Did the Court Analyse the Issues?

The court’s analysis proceeded by first acknowledging that the primary thresholds for a Mareva injunction—a good arguable case and a real risk of dissipation—had been met. However, the judgment focused heavily on the "undertaking as to damages" and the claimant's duty of disclosure, which the court treated as fundamental to the exercise of its discretion under the Civil Law Act 1909.

1. The Good Arguable Case and Risk of Dissipation

The court accepted that Parastate had established a good arguable case against Mr. Wang for the US$5m. The evidence suggested that Mr. Wang was deeply involved in the management of the Babel Finance ecosystem and that there were serious questions to be answered regarding the handling of Parastate's investment. Similarly, the court found a real risk of dissipation, noting the nature of the assets involved and the defendants' conduct in the lead-up to the litigation.

2. The Undertaking as to Damages: A Substantive Requirement

The court emphasized that the undertaking as to damages is the "price" a claimant pays for the injunction. Andre Maniam J observed that for the undertaking to be meaningful, the court must be satisfied that the claimant has the financial wherewithal to honor it. Parastate’s evidence was found wanting. The court noted:

"As Parastate’s evidence of its ability to meet its undertaking as to damages was unsatisfactory, I set the quantum of the Mareva injunction at US$2.5m, half of the US$5m that Parastate had applied to injunct." (at [2])

The court rejected the argument that historical funding of US$11.8m was sufficient. It pointed out that Parastate had not provided a current balance sheet or any evidence of its current net asset value. The court was particularly concerned that Parastate’s assets might be held in cryptocurrency, which is notoriously volatile. If the market crashed, Parastate’s ability to pay damages would vanish. The court held that a claimant seeking such relief must provide a "clear and up-to-date picture" of its financial position.

3. Material Non-Disclosure and Practice Directions

The court took a dim view of Parastate’s failure to comply with the Supreme Court Practice Directions 2021. Specifically, Parastate failed to provide the information required by the Directions regarding the assets available to meet the undertaking. Furthermore, Parastate had omitted Undertakings 9 and 10 from the standard Form 25. Undertaking 9 requires the claimant not to enforce the order abroad without leave, and Undertaking 10 requires the claimant to notify the court of any foreign proceedings. The court relied on Bouvier, Yves Charles Edgar and another v Accent Delight International Ltd and another and another appeal [2015] 5 SLR 558, which states that such undertakings should "ordinarily" be given for worldwide Mareva injunctions.

The court found that these omissions amounted to material non-disclosure. In the context of ex parte applications, the duty of full and frank disclosure is absolute. Even though this matter eventually proceeded inter partes, the initial failures tainted the application. The court cited JTrust Asia Pte Ltd v Group Lease Holdings Pte Ltd and others [2018] 2 SLR 159 at [84]–[92], noting that "Mareva relief may be refused in cases where the plaintiff has not come to court with clean hands."

4. The "Just or Convenient" Test and Calibration of Quantum

Under s 4(10) of the Civil Law Act 1909, the court must determine if the order is "just or convenient." The court reasoned that while it might be "just" to grant some protection to Parastate, it was not "just" to grant the full US$5m protection when the defendant was left with an unsecured and potentially worthless undertaking as to damages. The court used the quantum of the injunction as a "dial" to balance the equities. By halving the quantum to US$2.5m, the court reduced the potential exposure of the defendant, thereby making the claimant's questionable undertaking more "proportionate" to the risk.

The court also considered Maldives Airport Co Ltd and another v GMR Male International Airport Pte Ltd [2013] 2 SLR 449, where the Court of Appeal had set aside an injunction due to the inadequacy of the undertaking. Andre Maniam J chose a middle path: rather than refusing the injunction entirely, he limited its scope to reflect the evidentiary gaps and procedural lapses.

What Was the Outcome?

The court granted the Mareva injunction against Mr. Wang Li, but with a significant limitation on the quantum. The operative order was as follows:

"I granted the Mareva injunction against Mr Wang, but for a quantum of US$2.5m instead of $5m as sought by Parastate." (at [10])

The injunction was worldwide in scope, prohibiting Mr. Wang from disposing of or dealing with his assets up to the value of US$2.5m. However, the court's decision to halve the quantum was a direct consequence of Parastate's failure to provide satisfactory evidence of its financial standing and its failure to comply with the Practice Directions. The court effectively found that while Parastate had a good arguable case for US$5m, it had only "paid the price" (via its undertaking) for US$2.5m of protection.

In addition to the quantum reduction, the court required Parastate to include the standard undertakings it had previously omitted, ensuring that the worldwide nature of the order would be subject to the court's ongoing supervision regarding foreign enforcement. The costs of the application were not definitively settled in the primary judgment but the reduction in quantum represented a partial defeat for the claimant, which would typically be reflected in the costs award. Parastate subsequently filed an appeal against the decision to limit the quantum to US$2.5m.

Why Does This Case Matter?

This case is a landmark for practitioners involved in high-stakes commercial litigation, particularly those dealing with cryptocurrency and tech startups. It clarifies the "price of admission" for obtaining Mareva relief in Singapore and reinforces the court's role as a gatekeeper against procedural laxity.

1. The Reality of the Undertaking as to Damages

For too long, the undertaking as to damages was viewed by some as a "boilerplate" requirement. Parastate makes it clear that the court will look behind the promise. In an era where many claimants are Special Purpose Vehicles (SPVs) or startups with fluctuating asset values, the court will demand contemporary, granular financial data. Relying on "funding rounds" or "valuations" is no longer enough; the court wants to see the balance sheet. This is especially true in the cryptocurrency sector, where a claimant might be "rich" one day and "insolvent" the next.

2. Quantum as a Discretionary Tool

The judgment introduces a nuanced approach to the "all or nothing" dilemma of Mareva injunctions. Traditionally, if a claimant had a good arguable case for $X, the injunction was granted for $X. Andre Maniam J’s approach suggests that the court can use quantum as a tool to balance the risk of an inadequate undertaking. This "calibration" approach allows the court to provide some protection to the claimant while limiting the potential prejudice to the defendant. It is a pragmatic solution to the problem of "unreliable" claimants.

3. Strict Adherence to Practice Directions

The case serves as a stern warning regarding the Supreme Court Practice Directions 2021. The court’s refusal to overlook the omission of Undertakings 9 and 10 from Form 25 demonstrates that these forms are not merely "suggested" templates but mandatory standards. Practitioners who "edit" these forms to favor their clients do so at the risk of having their applications dismissed or their relief severely curtailed. The duty of full and frank disclosure extends to the form of the order being sought, not just the facts of the case.

4. Impact on Cryptocurrency Litigation

As Singapore continues to be a hub for crypto-disputes, this case sets a precedent for how the financial health of crypto-entities will be assessed. The court’s skepticism toward historical funding in a volatile market is a signal that crypto-claimants must be prepared to disclose their "cold wallet" balances and fiat reserves if they want the court's assistance in freezing a defendant's assets. The "crypto winter" context of the judgment shows that the court is alive to market realities.

Practice Pointers

  • Contemporary Financial Disclosure: When acting for a claimant, ensure that the supporting affidavit includes a current balance sheet or a detailed statement of assets. Do not rely on historical funding rounds or "valuation" figures from more than six months ago.
  • Crypto-Asset Transparency: If the claimant’s assets are primarily in cryptocurrency, provide a breakdown of the holdings and their current fiat value. Address the volatility of these assets and, if possible, offer additional security (such as a bank guarantee or payment into court) to bolster the undertaking.
  • Strict Compliance with Form 25: Use the standard Form 25 from the Practice Directions without unauthorized modifications. If any undertaking is to be omitted, it must be flagged to the court with a compelling legal justification.
  • The "Clean Hands" Audit: Before filing ex parte, conduct a rigorous internal audit of all material facts, including the claimant’s own financial vulnerabilities. Failure to disclose these can be characterized as material non-disclosure.
  • Inter Partes Strategy: If the court directs an ex parte application to be heard inter partes, use the intervening time to fortify the evidence regarding the undertaking as to damages. The court is likely to be more demanding of financial proof once the defendant has had a chance to challenge the claimant's standing.
  • Quantum Calibration: Be prepared to argue for a "staged" or "reduced" quantum if the claimant's financial position is complex. It may be better to secure a smaller, "safe" injunction than to risk the entire application being set aside for an inadequate undertaking.

Subsequent Treatment

As of the date of the judgment, Parastate Labs Inc had indicated its intention to appeal the reduction of the quantum to US$2.5m. The principles articulated by Andre Maniam J regarding the necessity of contemporary financial disclosure for undertakings as to damages have been noted in subsequent practitioner commentaries as reinforcing the "draconian" nature of the Mareva relief and the high bar for claimants. The case stands as a primary authority for the proposition that historical funding is not a substitute for current liquidity in the context of injunctive relief.

Legislation Referenced

  • Civil Law Act 1909 (2020 Rev Ed): Section 4(10) – The statutory basis for the court's power to grant injunctions where it is "just or convenient."
  • Supreme Court Practice Directions 2021: Form 25 (Standard Form of Mareva Injunction) – Specifically Undertakings 9 and 10 regarding foreign enforcement.

Cases Cited

Source Documents

Written by Sushant Shukla
1.5×

More in

Legal Wires

Legal Wires

Stay ahead of the legal curve. Get expert analysis and regulatory updates natively delivered to your inbox.

Success! Please check your inbox and click the link to confirm your subscription.